Literature DB >> 28417216

Pathogenic mechanisms following ischemic stroke.

Seyed Esmaeil Khoshnam1, William Winlow2,3, Maryam Farzaneh4, Yaghoob Farbood5, Hadi Fathi Moghaddam5.   

Abstract

Stroke is the second most common cause of death and the leading cause of disability worldwide. Brain injury following stroke results from a complex series of pathophysiological events including excitotoxicity, oxidative and nitrative stress, inflammation, and apoptosis. Moreover, there is a mechanistic link between brain ischemia, innate and adaptive immune cells, intracranial atherosclerosis, and also the gut microbiota in modifying the cerebral responses to ischemic insult. There are very few treatments for stroke injuries, partly owing to an incomplete understanding of the diverse cellular and molecular changes that occur following ischemic stroke and that are responsible for neuronal death. Experimental discoveries have begun to define the cellular and molecular mechanisms involved in stroke injury, leading to the development of numerous agents that target various injury pathways. In the present article, we review the underlying pathophysiology of ischemic stroke and reveal the intertwined pathways that are promising therapeutic targets.

Entities:  

Keywords:  Apoptosis; Inflammation; Ischemia; Oxidative stress; Stroke

Mesh:

Year:  2017        PMID: 28417216     DOI: 10.1007/s10072-017-2938-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  322 in total

1.  Adenovirus-mediated transfer of Bcl-X(L) protects neuronal cells from Bax-induced apoptosis.

Authors:  N Shinoura; R Satou; Y Yoshida; A Asai; T Kirino; H Hamada
Journal:  Exp Cell Res       Date:  2000-02-01       Impact factor: 3.905

Review 2.  Life-or-death decisions by the Bcl-2 protein family.

Authors:  J M Adams; S Cory
Journal:  Trends Biochem Sci       Date:  2001-01       Impact factor: 13.807

Review 3.  Mitochondrial aging: open questions.

Authors:  K B Beckman; B N Ames
Journal:  Ann N Y Acad Sci       Date:  1998-11-20       Impact factor: 5.691

4.  Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a role for transforming growth factor beta.

Authors:  V A Vincent; F J Tilders; A M Van Dam
Journal:  Glia       Date:  1997-03       Impact factor: 7.452

5.  A novel stroke therapy of pharmacologically induced hypothermia after focal cerebral ischemia in mice.

Authors:  Ko-Eun Choi; Casey L Hall; Jin-Mei Sun; Ling Wei; Osama Mohamad; Thomas A Dix; Shan P Yu
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

6.  Repetitive hypoxia extends endogenous neurovascular protection for stroke.

Authors:  Ann M Stowe; Tamer Altay; Angela B Freie; Jeffrey M Gidday
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

Review 7.  The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration.

Authors:  Jeffrey A Johnson; Delinda A Johnson; Andrew D Kraft; Marcus J Calkins; Rebekah J Jakel; Marcelo R Vargas; Pei-Chun Chen
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Permanent focal brain ischemia induces isoform-dependent changes in the pattern of Na+/Ca2+ exchanger gene expression in the ischemic core, periinfarct area, and intact brain regions.

Authors:  Francesca Boscia; Rosaria Gala; Giuseppe Pignataro; Andrea de Bartolomeis; Maria Cicale; Alberto Ambesi-Impiombato; Gianfranco Di Renzo; Lucio Annunziato
Journal:  J Cereb Blood Flow Metab       Date:  2006-04       Impact factor: 6.200

9.  Synergistic effects of caspase inhibitors and MK-801 in brain injury after transient focal cerebral ischaemia in mice.

Authors:  J Ma; M Endres; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

Review 10.  Classification of stroke subtypes.

Authors:  P Amarenco; J Bogousslavsky; L R Caplan; G A Donnan; M G Hennerici
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

View more
  138 in total

Review 1.  Ischemic stroke and mitochondria: mechanisms and targets.

Authors:  Syed Suhail Andrabi; Suhel Parvez; Heena Tabassum
Journal:  Protoplasma       Date:  2019-10-14       Impact factor: 3.356

Review 2.  The role of non-coding RNAs in neuroprotection and angiogenesis following ischemic stroke.

Authors:  Elaheh Heydari; Masoumeh Alishahi; Farhoodeh Ghaedrahmati; William Winlow; Seyed Esmaeil Khoshnam; Amir Anbiyaiee
Journal:  Metab Brain Dis       Date:  2019-08-24       Impact factor: 3.584

3.  Post-injury Nose-to-Brain Delivery of Activin A and SerpinB2 Reduces Brain Damage in a Mouse Stroke Model.

Authors:  Bettina Buchthal; Ursula Weiss; Hilmar Bading
Journal:  Mol Ther       Date:  2018-07-23       Impact factor: 11.454

Review 4.  Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases.

Authors:  Jogen Atone; Karen Wagner; Kenji Hashimoto; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2019-11-05       Impact factor: 3.072

5.  Lower uric acid is associated with poor short-term outcome and a higher frequency of posterior arterial involvement in ischemic stroke.

Authors:  Hanxiang Liu; Gavin P Reynolds; Wenmin Wang; Xianwen Wei
Journal:  Neurol Sci       Date:  2018-03-06       Impact factor: 3.307

6.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

Review 7.  Long non-coding RNAs and cell death following ischemic stroke.

Authors:  Masoumeh Alishahi; Farhoodeh Ghaedrahmati; Tannaz Akbari Kolagar; William Winlow; Negin Nikkar; Maryam Farzaneh; Seyed Esmaeil Khoshnam
Journal:  Metab Brain Dis       Date:  2019-05-04       Impact factor: 3.584

Review 8.  Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes.

Authors:  Marieke C S Boshuizen; Gary K Steinberg
Journal:  Stroke       Date:  2018-05-03       Impact factor: 7.914

9.  Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.

Authors:  Yi-Yue Zhang; Wei-Ning Liu; Yue-Qi Li; Xiao-Jie Zhang; Jie Yang; Xiu-Ju Luo; Jun Peng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-05       Impact factor: 3.000

Review 10.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.